Announcements Trials
Browse Landscape

Phase

Phase 1/2 3

Status

Active not recruiting 2Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 2Other solid neoplasm 2Gynecologic 2Breast 1

Conditions

Leukemia, Myeloid, Acute 35Recurrence 27Multiple Myeloma 27Leukemia, Lymphocytic, Chronic, B-Cell 27Lymphoma, Non-Hodgkin 25Lymphoma 20Neoplasms 16Lymphoma, Large B-Cell, Diffuse 16Lymphoma, B-Cell 15Lymphoma, Follicular 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, Mantle-Cell 13Leukemia 13Carcinoma, Non-Small-Cell Lung 13Stomach Neoplasms 11Ovarian Neoplasms 9Pancreatic Neoplasms 8Neoplasm Metastasis 8Triple Negative Breast Neoplasms 7Squamous Cell Carcinoma of Head and Neck 7Head and Neck Neoplasms 7Carcinoma, Renal Cell 7Uterine Cervical Neoplasms 6Myelodysplastic Syndromes 6Melanoma 6Lymphoma, B-Cell, Marginal Zone 6Breast Neoplasms 6Prostatic Neoplasms 5Liposarcoma, Myxoid 5Colorectal Neoplasms 5

Interventions

Gemcitabine 28pembrolizumab 24Cisplatin 24Fluorouracil 11Leucovorin 10Oxaliplatin 8Nivolumab 7Capecitabine 6Irinotecan 5Drug Therapy 5pemigatinib 4futibatinib 4Paclitaxel 4Carboplatin 4ivosidenib 3fludarabine 3durvalumab 3derazantinib 3Folfox protocol 3Cyclophosphamide 3Bevacizumab 3zanidatamab 2spartalizumab 2olutasidenib 2lenvatinib 2infigratinib 2budigalimab 2Trastuzumab 2Ipilimumab 2Injections 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Cholangiocarcinoma × fludarabine × Clear all
NCT07641036 2026-06-11

DUET-BTC

Beijing Biotech

Phase 1/2 Recruiting
30 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT03907852 2025-08-27

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

TCR2 Therapeutics

Phase 1/2 Active not recruiting
57 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Cholangiocarcinoma

NCT05451849 2025-08-27

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

TCR2 Therapeutics

Phase 1/2 Active not recruiting
6 enrolled
BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡